Signaturefd, LLC Maravai Lifesciences Holdings, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 6,420 shares of MRVI stock, worth $35,310. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,420

Previous 6,776 5.25%

Holding current value

$35,310

Previous $48,000 10.42%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$6.84 - $9.73 $2,435 - $3,463	-356 Reduced 5.25%	6,420 $53,000
Q2 2024 Jul 29, 2024	BUY	$6.87 - $11.34 $4,630 - $7,643	674 Added 11.05%	6,776 $48,000
Q1 2024 May 03, 2024	BUY	$5.11 - $8.76 $7,511 - $12,877	1,470 Added 31.74%	6,102 $52,000
Q4 2023 Jan 31, 2024	BUY	$4.7 - $9.87 $5,959 - $12,515	1,268 Added 37.69%	4,632 $30,000
Q3 2023 Nov 03, 2023	BUY	$9.14 - $12.85 $15,364 - $21,600	1,681 Added 99.88%	3,364 $33,000
Q2 2023 Aug 01, 2023	SELL	$12.09 - $15.0 $37,648 - $46,710	-3,114 Reduced 64.92%	1,683 $20,000
Q1 2023 Apr 28, 2023	BUY	$12.99 - $16.48 $36,826 - $46,720	2,835 Added 144.5%	4,797 $67,000
Q4 2022 Jan 27, 2023	BUY	$12.5 - $24.78 $9,500 - $18,832	760 Added 63.23%	1,962 $28,000
Q3 2022 Nov 08, 2022	BUY	$20.6 - $30.37 $16,521 - $24,356	802 Added 200.5%	1,202 $31,000
Q4 2021 Jan 25, 2022	BUY	$35.0 - $45.94 $7,000 - $9,188	200 Added 100.0%	400 $17,000
Q3 2021 Oct 28, 2021	BUY	$36.8 - $60.62 $7,359 - $12,124	200 New	200 $10,000

Others Institutions Holding MRVI

# of Institutions

234

Shares Held

140M

Call Options Held

223K

Put Options Held

19.4K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $723M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account